Immunity, inflammation and reservoir in patients at an early stage of HIV infection on intermittent ART (ANRS 141 TIPI Trial) | Zendy

Lionel Piroth | Zendy; Laëtitia Moinot | Zendy; Patrick Yéni | Zendy; Véronique Avettand-Fènoël | Zendy; Jacques Reynes | Zendy; PierreMarie Girard | Zendy; B. Marchou | Zendy; Aurore Georget | Zendy; Christine Rouzioux | Zendy; Brigitte Autran | Zendy; Laurence Duvillard | Zendy; Geneviève Chêne | Zendy; Catherine Fagard | Zendy

Open Access

Immunity, inflammation and reservoir in patients at an early stage of HIV infection on intermittent ART (ANRS 141 TIPI Trial)

Author(s) -

Lionel Piroth,

Laëtitia Moinot,

Patrick Yéni,

Véronique Avettand-Fènoël,

Jacques Reynes,

PierreMarie Girard,

B. Marchou,

Aurore Georget,

Christine Rouzioux,

Brigitte Autran,

Laurence Duvillard,

Geneviève Chêne,

Catherine Fagard

Publication year - 2015

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkv369

Subject(s) - medicine , nadir , cd8 , human immunodeficiency virus (hiv) , cd38 , gastroenterology , immunology , immune system , biology , satellite , stem cell , cd34 , engineering , genetics , aerospace engineering

The objective of this study was to assess clinical and biological changes during intermittent ART (I-ART) started early, with significant time spent on versus off ART, which has never before been studied in ART-naive patients with high nadir and current CD4 cell count.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research